DTwP-HepB-Hib vaccine (Crucell/Novartis Vaccines)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDTwP-HepB-Hib vaccine (Crucell/Novartis Vaccines)
Drug Alias NameDTP-HepB-HibDTwP-HepB-HibFully liquid 5-in-1 pentavalent vaccineQuinvaxem
ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BTetanusDiphtheria +[5] 
Global Approved IndicationsHepatitis BTetanusDiphtheria +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2006/03/01
Country/TerritoryVietnamPhilippinesSouth Korea +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma AgCrucell Holland Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrucell Holland BvNovartis Vaccines
Active IndicationsHepatitis BTetanusDiphtheria +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07CA11
Related LinksN/A